INFINITY PHARMACEUTICALS, INC. The US Bankruptcy Court approved disclosure statement on interim basis and combined hearing approval for prepackaged plan and disclosure statement of Infinity Pharmaceuticals, Inc., on February 1, 2024. The debtor had filed its solicitation version of disclosure statement and plan in the Court on February 1, 2024. The voting record date is February 1, 2024.
The deadline to vote on the plan is February 29, 2024. Any objections to the plan should be made before February 8, 2024, and the confirmation hearing for the plan and disclosure statement has been scheduled for March 7, 2024.
